Cannabis Law Report
SEPTEMBER 22, 2021
A Home Office spokesperson said: “There is an established process for the development of medicines, which enables medicines including psilocybin to be developed, evaluated in clinical trials and licensed based on an assessment of their quality, safety and efficacy. Source: [link].
Cannabis Law Report
JUNE 10, 2021
The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JANUARY 13, 2023
10 A 2001 review paper by cannabis researcher Dr. Ethan Russo details the historical use of cannabis for migraines. Russo concluded the evidence he examined “supports experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.”
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.
The Cannigma
OCTOBER 19, 2021
A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. CBD and alcohol safety.
Cannabis Law Report
NOVEMBER 13, 2019
They are learning quickly from the successes and failures in Canada’s legal medical cannabis program that has been active since 2001. The roadmap ahead includes clinical trials and more research in Denmark. Hundreds of GPs have prescribed medical cannabis and thousands of patients have received prescriptions in Denmark.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Only one article appeared in the MJA in 2000 and again in 2001. 24), and conveyed safety concerns ( n ?=?23).
Expert insights. Personalized for you.
52 
Let's personalize your content